BenQ Medical Technology Corp. Statistics
BenQ Medical Technology Corp. (4116) Stock Statistics & Valuation Metrics
Total Valuation
BenQ Medical Technology Corp. has a market cap or net worth of TWD 1.80B. The enterprise value is TWD 3.86B.
- Market Cap
- TWD 1.80B
- Enterprise Value
- TWD 3.86B
Share Statistics
BenQ Medical Technology Corp. has 44,566,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 44,566,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BenQ Medical Technology Corp.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.05%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 5.05%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 12.97M
- Profits Per Employee
- 193.02K
- Employee Count
- 405
- Asset Turnover
- 0.96
- Inventory Turnover
- 3.99
Valuation Ratios
The current PE Ratio of BenQ Medical Technology Corp. is 2.39. BenQ Medical Technology Corp.’s PEG ratio is 0.00.
- PE Ratio
- 2.39
- PS Ratio
- 0.34
- PB Ratio
- 1.76
- Price to FCF
- 5.30
- Price to Operating Cash Flow
- 4.82
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, BenQ Medical Technology Corp. had revenue of 5.25B and earned 78.17M in profits. Earnings per share was 1.75.
- Revenue
- 5.25B
- Gross Profit
- 1.69B
- Operating Income
- 342.42M
- Pretax Income
- 334.58M
- Net Income
- 78.17M
- EBITDA
- 611.55M
- Earnings Per Share (EPS)
- 1.75
Cash Flow
In the last 12 months, operating cash flow was 404.12M and capital expenditures -61.16M, giving a free cash flow of 342.96M billion.
- Operating Cash Flow
- 404.12M
- Free Cash Flow
- 342.96M
- Free Cash Flow per Share
- 7.19
Dividends & Yields
BenQ Medical Technology Corp. pays an annual dividend of ―, resulting in a dividend yield of 4.96%
- Dividend Per Share
- ―
- Dividend Yield
- 4.96%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 19.05%
- Earnings Yield
- 41.92%
Stock Price Statistics
- Beta
- 0.31
- 52-Week Price Change
- -13.32%
- 50-Day Moving Average
- 40.31
- 200-Day Moving Average
- 38.50
- Relative Strength Index (RSI)
- 44.90
- Average Volume (3m)
- 62.53K
Important Dates
BenQ Medical Technology Corp. upcoming earnings date is Mar 08, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Mar 08, 2027
- Ex-Dividend Date
- ―
Financial Position
BenQ Medical Technology Corp. as a current ratio of 1.62, with Debt / Equity ratio of 176.52%
- Current Ratio
- 1.62
- Quick Ratio
- 1.23
- Debt to Market Cap
- 0.30
- Net Debt to EBITDA
- 1.70
- Interest Coverage Ratio
- 7.67
Taxes
In the past 12 months, BenQ Medical Technology Corp. has paid 116.96M in taxes.
- Income Tax
- 116.96M
- Effective Tax Rate
- 0.35
Enterprise Valuation
BenQ Medical Technology Corp. EV to EBITDA ratio is 6.26, with an EV/FCF ratio of 8.48.
- EV to Sales
- 0.54
- EV to EBITDA
- 6.26
- EV to Free Cash Flow
- 8.48
- EV to Operating Cash Flow
- 7.19
Balance Sheet
BenQ Medical Technology Corp. has TWD 1.03B in cash and marketable securities with TWD 2.00B in debt, giving a net cash position of -TWD 968.83M billion.
- Cash & Marketable Securities
- TWD 1.03B
- Total Debt
- TWD 2.00B
- Net Cash
- -TWD 968.83M
- Net Cash Per Share
- -TWD 21.74
- Tangible Book Value Per Share
- TWD 41.61
Margins
Gross margin is 31.73%, with operating margin of 5.20%, and net profit margin of 14.96%.
- Gross Margin
- 31.73%
- Operating Margin
- 5.20%
- Pretax Margin
- 19.57%
- Net Profit Margin
- 14.96%
- EBITDA Margin
- 8.60%
- EBIT Margin
- 5.20%
Analyst Forecast
The average price target for BenQ Medical Technology Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.85%
- EPS Growth Forecast
- 786.65%
